Article by Sam Riches, Growth Op A Harvard study recently published in the journal Experimental and Clinical Psychopharmacology suggests that cannabis can be an effective treatment option for chronic pain sufferers. The findings arrive after recent statements from the International Association for the Study of Pain and the Australian and New Zealand College of Anaesthetists that saw neither organization back the use ...

Article by Travis Cesarone, Cannabis Life Network THC-O-acetate is a form (ester) of THC that is 300 percent stronger than regular THC. (1) Acetic acid – the compound in tabletop vinegar – can combine with THC to form this acetate ester. Does a similar chemical reaction occur if we used a cannabinoid acid and terpene alcohol, instead of acetic acid and active ...

Article by Ben Cousins, CTV New Doctors should not suggest vaping to help youth and adolescents quit smoking, according to new guidance from Canadian pediatricians. The Canadian Paediatric Society (CPS) recommended on Wednesday that vaping “should not be used as a smoking cessation or harm reduction strategy” in youth, saying that doctors should instead “assess their patient’s motivation to reduce ...

Article by Angela Stelmakowich, Growth Op Awareness campaigns are needed to inform cannabis smokers that using weed can affect their vision to such a degree that it might negatively influence their ability to carry out everyday tasks, new research out of Spain suggests. A group of investigators from the University of Granada’s Department of Optics found that smoking weed appears ...

Article by Fallon Hewitt, Hamilton Spectator A recent study carried out by McMaster University shows that Ontario physicians are still reluctant to authorize medical cannabis even two decades after it was legalized in Canada. And the reasons behind that reluctance range from concerns about damaging after-effects to a general lack of “proper guidance,” said Jason Busse, associate director of the Michael ...

Article by Thor Diakow, Coast Reporter This October marks three years since the Cannabis Act (otherwise known as Bill C-45) was implemented in Canada, effectively legalizing recreational marijuana in the country. Pot policymakers and industry experts continue to refine the complex market. One of the recurring issues is packaging, specifically for dried cannabis flowers. David Brown is a former senior policy advisor ...

Article by Angela Stelmakowich, Growth Op What is being called the first study to consider specific risk indicators for cardiovascular disease (CVD) in young, healthy cannabis users has found that consuming weed when young may increase the risk of later developing heart disease. So suggests a new study, published in the Journal of Applied Physiology, out of the University of Guelph ...

Article by Scitech Daily Ontario doctors are still hesitant to prescribe medical cannabis to patients suffering long-term pain 20 years after it was first introduced, says a new study carried out at McMaster University. Physicians surveyed said their main concerns relate to possible ill-effects and a lack of understanding regarding their effectiveness as painkillers. Of particular concern among doctors were ...

Article by Sam Riches, Growth Op Researchers at McMaster University made a surprising discovery last winter. In a mice study, they found that the nonpsychoactive cannabinoid cannabigerol (CBG) was not only a potent microbial agent but was also capable of killing the superbug methicillin-resistant Staphylococcus aureus (MRSA). Resistant to several antibiotics, MRSA can spread in hospitals, and other healthcare facilities, and ...

Article by Marijuana Business Daily Canada’s federal health department will no longer be releasing cannabis industry data on a monthly basis, a spokesperson for Health Canada told Marijuana Business Daily, citing priorities related to the ongoing pandemic. “We are working in prioritization mode in order to ensure that information most vital to the wellbeing and safety of Canadians is being published ...